INS and diabetes mellitus: The use of sulfonylureas (n = 46, 29.9% of the population with diabetes) was associated with a greater decline in endothelial microvascular function compared with those with diabetes on other therapies, including insulin, after adjustment for the HbA1c effect (adjusted standardised β 0.199, p = 0.02).